Related Experiment Video
Updated: May 23, 2026

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
Clinical Indications of C-Choline PET/CT in Prostate Cancer Patients with Biochemical Relapse
Maria Picchio1, Paolo Castellucci
11. Nuclear Medicine Department, San Raffaele Scientific Institute, Milan, Italy; Institute for Bioimaging and Molecular Physiology, National Research Council (IBFM-CNR), Milan, Italy;
Abstract:
Several studies investigated the potential role of imaging modalities in prostate cancer patients in case of biochemical recurrence. However, the role of molecular imaging has not been well established yet. Considering the results of the literature and of our own experience, we tried to summarize the potential applications of (11)C-choline PET/CT in prostate cancer patients in case of biochemical relapse for the detection of lymph node and distant recurrence.
Related Concept Videos
Positron Emission Tomography
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...

